BTG Pactual Asset Management US’s CME Group CME Stock Holding History

BTG Pactual Asset Management US’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,047	Closed	-$278K	–	267
2025 Q1	$278K	Sell	1,047 -1,551	-60%	-$383K	0.03%	192
2024 Q4	$603K	Buy	+2,598	New	+$597K	0.06%	168

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BTG Pactual Asset Management US's CME Position: Q2 2025 in Review

BTG Pactual Asset Management US sold out of CME Group (CME) in Q2 2025, closing a stake of 1,047 shares — an estimated $278K sold.

BTG Pactual Asset Management US first reported a position in CME in Q4 2024 and held it in 2 quarters. The position peaked at $603K in Q4 2024. 1,662 funds tracked by Wall St. Rank hold CME as of Q2 2025.

BTG Pactual Asset Management US reported no remaining CME Group position as of Q2 2025 after selling out during the quarter.
BTG Pactual Asset Management US sold 1,047 CME Group shares in Q2 2025, an estimated $278K.
BTG Pactual Asset Management US first reported a position in CME Group in Q4 2024 and held it in 2 quarters.
BTG Pactual Asset Management US's CME Group position peaked at $603K in Q4 2024.
1,662 funds tracked by Wall St. Rank held CME Group as of Q2 2025.

Based on BTG Pactual Asset Management US's 13F filing for Q2 2025, filed 14 Aug 2025.